- Home
- Companies
- north america
- depressive disorder
Show results for
Refine by
Industries served
- Medical / Health Care
- Chemical & Pharmaceuticals
- Manufacturing, Other
- Automobile & Ground Transport
- Defense
- Electronics and Computers
- Aerospace & Air Transport
- Waste and Recycling
- Oil, Gas & Refineries
- Monitoring and Testing
- Environmental
- Health and Safety
- Air and Climate
- University / Academia / Research
- Government
- Food and Beverage
Depressive Disorder Suppliers In North America
12 companies found
based inNew York, NEW YORK (USA)
We develop, validate, and commercialize software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are ...
Click is researching multiple cognitive exercises for the treatment of ...
based inLos Angeles, CALIFORNIA (USA)
NeuroSigma is a California-based life sciences company established to develop bioelectronic technologies with the potential to transform medical practice and patients' lives. NeuroSigma is focused on TNS neuromodulation therapies based on ...
based inBurlington, MASSACHUSETTS (USA)
BrainsWay focuses on developing cutting-edge medical devices that help advance the level of treatment offered to patients. To do so, BrainsWay’s advanced flagship technology of Deep Transcranial Magnetic Stimulation (Deep TMS) is expanding the ...
based inCoral Gables, FLORIDA (USA)
We are a late-stage biotech company addressing diseases of the central nervous system (CNS), with a focus on major depressive disorder (MDD). Our experienced and dedicated team is committed to making a difference in the lives of patients and their ...
REL-1017 is a novel N-methyl-D-aspartate receptor (NMDAR) channel blocker in phase 3 clinical trials for the treatment of Major Depressive Disorder (MDD). REL-1017 works with a MOA markedly different from standard ...
based inBellevue, WASHINGTON (USA)
EMulate Therapeutics is a clinical-stage therapeutic device company utilizing its patented proprietary radio frequency energy (RFE) technology, targeted at the low and ultra-low ends of the RFE spectrum (ulRFE®), to provide safe and effective ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Dexamethasone (Hexadecadrol) is a glucocorticoid receptor agonist, apoptosis inducer, and common disease inducer in experimental animals, constructing models of muscle atrophy, hypertension, and depression. Dexamethasone can inhibit the production ...
based inHaymarket, AUSTRALIA
We build digital brain maps. Imagine trying to navigate the world without a map. You might struggle to find the right way, take a few wrong turns, bump into something unexpected, or remain lost forever. You might get to your destination, but it ...
Infinitome is a next-generation neuro research platform that enables groundbreaking data and image analysis of the brain - without the need for code. Our cloud-driven, HIPAA compliant research platform turns raw MRI data into detailed functional ...
based inInnsbruck, AUSTRIA
IONICON is the world's leading manufacturer of ultra-sensitive real-time trace gas analyzers based on the unique Proton Transfer Reaction – Mass Spectrometry (PTR-MS) and proprietary SRI-MS technology. IONICON also produces industrial process ...
based inGeneva, SWITZERLAND
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available, small molecule drugs known as allosteric modulators for neurological disorders. Allosteric ...
mGlu2 NAM for the treatment of mild neurocognitive disorders, or mNCD. We are developing mGlu2 NAM as a novel orally available treatment for mNCD associated with Alzheimer’s disease, Parkinson’s disease and ...
based inMalvern, PENNSYLVANIA (USA)
NeuroStar is the market leader in Transcranial Magnetic Stimulation technology for the treatment of Major Depressive Disorder. Based in Malvern, PA, we are a public medical device company (STIM) focused on developing non-invasive therapies for ...
based inNew Haven, CONNECTICUT (USA)
BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company utilizing artificial intelligence, or AI, approaches to develop transformative medicines in neuroscience and immuno-oncology. We are focused on utilizing cutting-edge ...
It is being investigated for at-home use for the acute treatment of agitation in bipolar and schizophrenia patients, for agitation in Alzheimer’s disease, and as an adjunctive treatment for major depressive ...
based inPrinceton, NEW JERSEY (USA)
Otsuka Pharmaceutical Co., Ltd. is a global healthcare company with the corporate philosophy: “Otsuka–people creating new products for better health worldwide.” Otsuka researches, develops, manufactures, and markets innovative products, with a focus ...
After it is swallowed, ABILIFY MYCITE® (aripiprazole tablets with sensor) sends a tiny signal to a wearable Bluetooth®* patch that connects with your smartphone, allowing you to see your daily data all in one ...